Literature DB >> 12699893

Application of comparative genomic hybridization in search for genetic aberrations in fibroadenomas of the breast.

A Amiel1, Z Kaufman, E Goldstein, R Bar-Sade Bruchim, D Kidron, E Gaber, M D Fejgin.   

Abstract

We applied a comparative genomic hybridization (CGH) technique to paraffin-embedded tissue samples taken from fibroadenomas, benign breast tumors, to detect possible numerical and unbalanced genetic changes. We compared the results to those from previous cytogenetic studies of fibroadenomas. In concurrence with previous cytogenetic studies of fibroadenomas, we detected genetic aberrations in chromosomes 4-6, 8-13, 16, 18, 19, 20, and 22. In addition, with the CGH technique we were able to find two new aberrations, 15q+ and 16p-. Because these aberrations have also been reported to be present in breast cancer, the importance of this finding is yet to be determined.

Entities:  

Mesh:

Year:  2003        PMID: 12699893     DOI: 10.1016/s0165-4608(02)00833-6

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  2 in total

1.  NUCKS overexpression in breast cancer.

Authors:  Yiannis Drosos; Mirsini Kouloukoussa; Anne Carine Østvold; Kirsten Grundt; Nikos Goutas; Dimitrios Vlachodimitropoulos; Sophia Havaki; Panagoula Kollia; Christos Kittas; Evangelos Marinos; Vassiliki Aleporou-Marinou
Journal:  Cancer Cell Int       Date:  2009-08-10       Impact factor: 5.722

2.  Genetic differences between benign phyllodes tumors and fibroadenomas revealed through targeted next generation sequencing.

Authors:  Cedric Chuan Young Ng; Nur Diyana Md Nasir; Benjamin Nathanael Loke; Timothy Kwang Yong Tay; Aye Aye Thike; Vikneswari Rajasegaran; Wei Liu; Jing Yi Lee; Peiyong Guan; Abner Herbert Lim; Kenneth Tou En Chang; Mihir Ananta Gudi; Preetha Madhukumar; Benita Kiat Tee Tan; Veronique Kiak Mien Tan; Chow Yin Wong; Wei Sean Yong; Gay Hui Ho; Kong Wee Ong; George Wai Cheong Yip; Boon Huat Bay; Patrick Tan; Bin Tean Teh; Puay Hoon Tan
Journal:  Mod Pathol       Date:  2021-03-16       Impact factor: 7.842

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.